Notification of buy-back - CYP
Released
Released
Announcement PDF
Appendix 3C - Notification of buy-back
Appendix 3C - Notification of buy-back 1 / 5
Announcement Summary
Name of entity
CYNATA THERAPEUTICS LIMITED
Announcement type
New announcement
Date of this announcement
20/10/2026
ASX Security code and description of the class of +securities the subject of the buy-back
CYP : ORDINARY FULLY PAID
The type of buy-back is:
Refer to next page for full details of the announcement
Selective buy-back
Appendix 3C - Notification of buy-back
Appendix 3C - Notification of buy-back 2 / 5
Part 1 - Entity and announcement details
1.1 Name of entity
CYNATA THERAPEUTICS LIMITED
We (the entity named above) provide the following information about our buy-back.
1.2 Registration number type
ACN
Registration number
104037372
1.3 ASX issuer code
CYP
1.4 The announcement is
1.5 Date of this announcement
20/10/2026
1.6 ASX Security code and description of the class of +securities the subject of the buy-back
CYP : ORDINARY FULLY PAID
New announcement
Appendix 3C - Notification of buy-back
Appendix 3C - Notification of buy-back 3 / 5
Part 2 - Type of buy-back
2.1 The type of buy-back is:
Selective buy-back
Appendix 3C - Notification of buy-back
Appendix 3C - Notification of buy-back 4 / 5
Part 3 - Buy-back details
Part 3A - Details of +securities, price and reason
3A.1 Total number of +securities on issue in the class of
+securities to be bought back
243,454,369
3A.2 Total number of +securities proposed to be bought
back
7,200,000
3A.3 Name of person or description of class of persons whose +securities are proposed to be bought back
Acuity Capital Investment Management Pty Ltd <Acuity Capital Holdings Account>
3A.9 Are the +securities being bought back for a cash consideration?
3A.9b Please describe the consideration being provided to buy back the +securities
Nil consideration pursuant to the buy-back agreement.
Part 3B - Buy-back restrictions and conditions
3B.1 Does the buy-back require security holder
approval?
3B.1a Type of security holder approval required
3B.1b Anticipated date of security holder meeting to
approve the buy-back
25/11/2026
3B.2 Are there any restrictions on foreign participation in
the buy-back
3B.3 Are there any other conditions that need to be
satisfied before the buy-back offer becomes
unconditional?
No
No
Special resolution
Yes
No
Appendix 3C - Notification of buy-back
Appendix 3C - Notification of buy-back 5 / 5
Part 3C - Key dates
Employee Share Scheme, Selective and Other Buy-Backs
3C.1 Anticipated date buy-back will occur
2/12/2026
Part 3D - Other Information
3D.1 Any other information the entity wishes to notify to ASX about the buy-back
Share your feedback
Discover